ArticleProceedings of the National Academy of Sciences of the United States of America2013

Autoantigen can promote progression to a more aggressive TCL1 leukemia by selecting variants with enhanced B-cell receptor signaling.

Shih-Shih Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.